(Q33280424)
Statements
1 reference
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts (English)
1 reference
Daniel L Gustafson
1 reference
Barbara Frederick
1 reference
Andrea L Merz
1 reference
David Raben
1 reference
29 March 2007
1 reference
1 reference
61
1 reference
179-188
1 reference
Identifiers
1 reference
1 reference